Rising eye care awareness and technological advancements is expected to drive the United States eye drops market for the forecast period.
According to TechSci Research report, “United States Eye Drops Market By Type (Prescription v/s Over-The-Counter) By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others) By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others) By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) By End User (Hospitals & Clinics, Homecare, Others) By Company, By Region, Forecast & Opportunities, 2026”, The United States eye drops market is expected to witness steady growth for the next five years. A large population is suffering from several eye disorders. Some of the disorders can be treated at home and some require treatment from eye specialist. Eye drops are recommended by ophthalmologist as they treat the eyes without any pain and are very effective in nature. Some of the common eye problems are dryness of eye, redness, soreness, refractive errors, itching, conjunctivitis, glaucoma, eye allergy and retinal disorders. Development of eye drops for treatment of rare eye disorders is expected to drive the growth of the eye cares market. Also, the presence of advanced technology to improve the biocompatibility and physicochemical stability to increase the efficiency and obtain better results is accelerating the growth of the eye cares market in United States.
The COVID-19 outbreak across the world which has been declared as pandemic by World Health Organization has affected countries adversely. Leading authorities in United States imposed lockdown restrictions and released a set of precautionary measures to contain the spread of novel coronavirus. Coronavirus affected patients started suffering from shortness of breath along with coughing and sneezing. United States authorities increased the capacity of hospitals as a greater number of patients were getting affected daily and getting admitted into the hospital facilities. Organizations gave the facility to employees to work from home which increased the screen time of the employees. Huge amount of time spent on electronic devices led to irritation and redness of eyes which is creating the lucrative opportunities for the eye care market growth.
Browse XX Figures spread through XX Pages and an in-depth TOC on “United States Eye Drops Market”.
United States eye drops market is segmented into type, drug class, disease indication, distribution channel, end user, regional distribution, and company. Based on type, eye drops market is divided into prescription and over-the-counter. The prescription segment is expected to hold major market share for the forecast period, 2022-2026 owing to presence of old age population and these drugs are more effective than its counterpart. These are used for medical treatments, such as cataract and post-surgery inflammations. Based on end user, market is majorly categorized into hospitals & clinics, homecare, and others. The hospitals & clinics segment is expected to dominate the eye drops market as there is high patient in-flow into the hospital facilities suffering from different eye-disorders. Favourable government reimbursement policies encouraging the consumers to avail healthcare facilities is increasing the market for healthcare sector. Based on drug class, market is fragmented into antiallergy, anti-inflammatory, antiglaucoma, anti-VEGF and others. The anti-VEGF segment is expected to hold significant share for the next five years. Increasing prevalence of dry eye disease in United States is boosting the sale of eye drops in United States. Based on disease indication, market is divided into dry eye diseases, glaucoma, eye allergy, eye infections, retinal disorders, and others. The retinol disorders segment is expected to hold lion’s share for the predicted period.
Bausch Health Companies, Inc., Alcon, Inc., Johnson & Johnson, Pfizer, Inc., Novartis Pharmaceuticals Corporation, Allergan, Inc. (AbbVie), Bayer Corporation, Genentech, Inc. (Roche), Akorn, Inc., KC Pharmaceuticals, Inc. are the leading players operating in United States eye drops market. Manufacturers are increasingly focusing on research and development process to fuel higher growth in the market. To meet evolving customer demand with respect to better efficiency and durability, several eye drops manufacturers are coming up with their technologically advanced offerings.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7483
Customers can also request for 10% free customization on this report.
“Increasing prevalence of cataract and retinol disorders in United State is boosting the eye drops market growth. High adoption of digital devices and surge in awareness regarding the benefits of eye drops is fostering the demand for eye drops in United States. Frequent travelling and rising pollution levels along with poor nutritive consumption is fostering the market growth. Market players are selling the eye drops through online platforms by offering lucrative discounts and offers to attract consumers and expand the market reach of their respective drops is expected to propel the growth of eye drops market until 2026” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Eye Drops Market By Type (Prescription v/s Over-The-Counter) By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others) By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others) By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy) By End User (Hospitals & Clinics, Homecare, Others) By Company, By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of United States eye drops market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in the of United States eye drops market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]